1. Home
  2. PDLB vs AQST Comparison

PDLB vs AQST Comparison

Compare PDLB & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDLB
  • AQST
  • Stock Information
  • Founded
  • PDLB 1960
  • AQST 2004
  • Country
  • PDLB United States
  • AQST United States
  • Employees
  • PDLB N/A
  • AQST N/A
  • Industry
  • PDLB
  • AQST Biotechnology: Pharmaceutical Preparations
  • Sector
  • PDLB
  • AQST Health Care
  • Exchange
  • PDLB Nasdaq
  • AQST Nasdaq
  • Market Cap
  • PDLB 330.3M
  • AQST 809.3M
  • IPO Year
  • PDLB 2017
  • AQST 2018
  • Fundamental
  • Price
  • PDLB $14.59
  • AQST $6.99
  • Analyst Decision
  • PDLB
  • AQST Strong Buy
  • Analyst Count
  • PDLB 0
  • AQST 7
  • Target Price
  • PDLB N/A
  • AQST $10.71
  • AVG Volume (30 Days)
  • PDLB 40.5K
  • AQST 3.6M
  • Earning Date
  • PDLB 10-30-2025
  • AQST 10-31-2025
  • Dividend Yield
  • PDLB N/A
  • AQST N/A
  • EPS Growth
  • PDLB 83.78
  • AQST N/A
  • EPS
  • PDLB 0.71
  • AQST N/A
  • Revenue
  • PDLB $90,513,000.00
  • AQST $44,132,000.00
  • Revenue This Year
  • PDLB $10.97
  • AQST N/A
  • Revenue Next Year
  • PDLB $8.59
  • AQST $51.50
  • P/E Ratio
  • PDLB $20.42
  • AQST N/A
  • Revenue Growth
  • PDLB 15.50
  • AQST N/A
  • 52 Week Low
  • PDLB $10.88
  • AQST $2.12
  • 52 Week High
  • PDLB $15.21
  • AQST $7.55
  • Technical
  • Relative Strength Index (RSI)
  • PDLB 50.93
  • AQST 63.34
  • Support Level
  • PDLB $14.01
  • AQST $6.78
  • Resistance Level
  • PDLB $14.79
  • AQST $7.55
  • Average True Range (ATR)
  • PDLB 0.31
  • AQST 0.41
  • MACD
  • PDLB -0.00
  • AQST 0.04
  • Stochastic Oscillator
  • PDLB 69.05
  • AQST 71.13

About PDLB Ponce Financial Group Inc.

Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Share on Social Networks: